Literature DB >> 24343208

Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care.

James Q Del Rosso1, Diane Thiboutot, Richard Gallo, Guy Webster, Emil Tanghetti, Larry Eichenfield, Linda Stein-Gold, Diane Berson, Andrea Zaenglein.   

Abstract

Rosacea is a common clinical diagnosis that encompasses a variety of presentations, predominantly involving the centrofacial skin. Reported to present most commonly in adults of Northern European heritage with fair skin, rosacea can affect males and females of all ethnicities and skin types. Pathophysiologic mechanisms that appear to correlate with the manifestation of rosacea have been the focus of multiple research studies, with outcomes providing a better understanding of why some individuals are affected and how their visible signs and symptoms develop. A better appreciation of the pathophysiologic mechanisms and inflammatory pathways of rosacea has allowed therapeutic strategies to be optimally incorporated. Part 1 of this 5-part series discusses the rosacea disease state with an emphasis on clinical correlation, reviews adjunctive skin care for cutaneous rosacea, and provides management caveats.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24343208

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  16 in total

Review 1.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

2.  Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS).

Authors:  James Q Del Rosso; Emil Tanghetti; Guy Webster; Linda Stein Gold; Diane Thiboutot; Richard L Gallo
Journal:  J Clin Aesthet Dermatol       Date:  2020-06-01

Review 3.  An update on the treatment of rosacea.

Authors:  Alexis Lara Rivero; Margot Whitfeld
Journal:  Aust Prescr       Date:  2018-02-01

4.  Augmented supraorbital skin sympathetic nerve activity responses to symptom trigger events in rosacea patients.

Authors:  Kristen Metzler-Wilson; Kumika Toma; Dawn L Sammons; Sarah Mann; Andrew J Jurovcik; Olga Demidova; Thad E Wilson
Journal:  J Neurophysiol       Date:  2015-07-01       Impact factor: 2.714

5.  Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions.

Authors:  Terry M Jones; Iain Stuart
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

Review 6.  The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review.

Authors:  Martin Schaller; Thomas Dirschka; Sol-Britt Lonne-Rahm; Giuseppe Micali; Linda F Stein Gold; Jerry Tan; James Del Rosso
Journal:  Acta Derm Venereol       Date:  2021-10-31       Impact factor: 3.875

7.  Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey.

Authors:  Joshua A Zeichner; Lawrence F Eichenfield; Steven R Feldman; J Scott Kasteler; Ilia L Ferrusi
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

Review 8.  Managing Rosacea in the Clinic: From Pathophysiology to Treatment-A Review of the Literature.

Authors:  Sandra Marchese Johnson; Andrew Berg; Chelsea Barr
Journal:  J Clin Aesthet Dermatol       Date:  2020-04-01

9.  The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.

Authors:  James Q Del Rosso; Emil A Tanghetti; Hilary E Baldwin; David A Rodriguez; Ilia L Ferrusi
Journal:  J Clin Aesthet Dermatol       Date:  2017-06-01

10.  The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea.

Authors:  Andrew William Johnson; Sandra Marchese Johnson
Journal:  Dermatol Ther (Heidelb)       Date:  2015-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.